Edition:
United States

Profile: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,550.00GBp
28 Apr 2017
Change (% chg)

-8.50 (-0.55%)
Prev Close
1,558.50
Open
1,556.00
Day's High
1,558.00
Day's Low
1,544.00
Volume
10,615,813
Avg. Vol
8,645,860
52-wk High
1,745.56
52-wk Low
1,363.00

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines, vaccines and consumer healthcare products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health categories. Its product portfolio includes Adartrel, Bexsero, Daraprim and Quinvaxem. Its brands include Panadol, abreva, polident and physiogel.

Company Address

GlaxoSmithKline PLC

980 Great West Road
BRENTFORD     TW8 9GS
P: +4420.80475000
F: +4420.80477807

Company Web Links